G&S Capital LLC Geron Corp Transaction History
G&S Capital LLC
- $218 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding GERN
# of Institutions
250Shares Held
374MCall Options Held
1.48MPut Options Held
1.18M-
Black Rock Inc. New York, NY41.4MShares$188 Million0.0% of portfolio
-
State Street Corp Boston, MA31.6MShares$143 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT30.5MShares$138 Million3.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.9MShares$135 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA27.2MShares$123 Million12.02% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.71B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...